While the world of cocktails may seem to be constantly evolving, year after year it's the classic recipes that customers continue to demand.

In its January issue, Drinks International released its list of the world's best-selling classic cocktails in 2019 — and it shows that while bartenders may put a modern spin on old recipes, the desire for established, sophisticated drinks remains.

The website asked bartenders from 127 of the best bars in 38 countries around the world — all of which have won or been nominated for global awards over the past year — to rank their 10 best-selling cocktails.

Read more: The 30 best-selling cocktails in the world in 2018

It then weighted and ranked each drink to compile the list.

From Moscow mules to mai tais, scroll down to see the 50 best-selling cocktails in the world, ranked in ascending order, and to see how many you've tried.

50. White Russian

Made popular in the '90s by "The Big Lebowski," this vodka, cream, and coffee-liqueur cocktail may not be as trendy as it once was, but it still made its way into the top 50.

49. Bellini

Invented by Giuseppe Cipriani, the founder of Harry's Bar in Venice, the Bellini may not be considered to be a cocktail by some, with only two ingredients — prosecco and peach purée or nectar.

48. Champagne Cocktail

Made with sugar, Angostura bitters, Champagne, brandy, and a maraschino cherry as a garnish, the Champagne Cocktail seems a little outdated next to some of its more modern contenders.

• Real estate consultancy Knight Frank's report on global ultra-prime destinations includes four ski destinations.
• Three of those are in the Alps, including St. Moritz, the hidden gem beloved by the 1%.
• Aspen is the only American market represented in the list of ultra-prime real estate markets.

The world's wealthiest people are buying homes in four main ski destinations globally, and they're focused mostly in the Alps. The only exception to the European dominance in this field — and it comes as no major surprise, given its reputation and prices — can be found in Aspen, Colorado.

That's according to a recent Knight Frank report on the global ultra-prime market, which looks at destinations that have seen at least three home sales over $25 million every year for the past three years running.

Those four ski destinations fit into a larger scheme of 17 total ultra-prime destinations, including cities like London, Hong Kong, and Singapore.

While the town is home to a year-round population of only about 7,400, Aspen has for years been recognized as a hot spot for the rich and famous, attracting the likes of Kim Kardashian and Kanye West, Elton John, and Jack Nicholson.

Media mogul Lachlan Murdoch numbers amongst the high net-worth individuals who have contributed to Aspen's ultra-prime standing; in 2017, he bought a $29 million mansion that includes a horse stable and a 300-bottle wine cellar.

Read more: 50 of the best ski resorts to visit this winter in the US and Canada, ranked from most expensive to least

The three European ski destinations can be found in St. Moritz, Courchevel, and Gstaad. The first two, in particular, are familiar names amongst celebrities and business moguls looking to kick back in style on and off the slopes, and both are host to resorts that have historically been listed amongst the most expensive in the world.

St. Moritz is, as Business Insider's Hillary Hoffower previously reported, a Swiss resort "... with world-class skiing, the birthplace of Alpine winter tourism, twice a home to the Winter Olympics, and a hidden gem for the one percent."

Gstaad, meanwhile, also in Switzerland, is home to the winter campus of the world's most expensive school, Switzerland's Institut Le Rosey.

SEE ALSO: A new report reveals the 17 most popular housing markets for the world's richest people, and a notoriously expensive city is missing from the list

Join the conversation about this story »

NOW WATCH: 4 tricks that will make hosting Thanksgiving dinner much easier this year

SEE ALSO: We compared Amazon and Costco prices to see which company offers better deals. Here's the verdict.

Costco doesn't require a membership to shop online, but a membership is necessary to access two-day delivery. The homepage of the website is very busy.

Jet's website is less busy, and free two-day delivery is advertised on all orders of $35 or more.

Costco's category page is also very busy. The large number of categories makes it more difficult to find things.

• Investors should keep an eye on 12 key new drugs going into 2019, according to Jefferies analyst Michael Yee.
• The medications range from a gene therapy that could be a game-changer for a rare disease to a CBD product for rare childhood epilepsy and a fish-based drug that could improve heart health.
• But new drug launches can be a bumpy time for companies, so buying shares in these drugmakers may not make sense, Yee said.

New year, new drug launches. 

In 2019, there are 12 medications investors should watch out for, according to Jefferies analyst Michael Yee. All of them have either been approved or could be soon.

They include the gene therapy that spurred a $9 billion acquisition, a CBD medication for rare types of childhood epilepsy, and a drug that could be the first specifically approved for postpartum depression. 

But in spite of all the activity, Yee urged caution on buying shares in these biotech companies.

His key point: Nothing lifts a biotech's stock like a new drug approval — but what happens after that, when companies actually have to sell that medication, is often a mixed bag.

Few small to mid-size biotech companies had unequivocally strong launches this past year, with the exception of the drugmaker Neurocrine Biosciences, Yee said. Meanwhile, the landscape for drugmakers going into 2019 remains tricky.

"Given the challenging glass-half-empty environment, we argue the hurdle seems even higher for companies to deliver in 2019," Yee said.

Here are Yee's picks for next year's key new medications:

1. An eczema medication expanding into asthma

Already sold for the skin-inflammation condition eczema, Regeneron's Dupixent was just approved as a maintenance medication for moderate-to-severe asthma in mid-October. The 2019 launch will be important, Yee said.

The connection between eczema and asthma may not appear obvious, but both are diseases where inflammation plays, or is thought to play, a role. Dupixent is also being tested out in many other inflammation-related diseases, including grass and peanut allergies, with plans to study it in chronic obstructive pulmonary disease, as well.

See more:A treatment for the most common food allergy could be available next year, and one biotech just drew ahead in the race for the $3 billion market

2. A longer-lasting rare disease drug

Alexion's blockbuster drug, Soliris, has been on the market for the ultra-rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) for 11 years. Also approved for other conditions, Soliris is a linchpin product for Alexion, having brought in nearly 90% of the biotech's 2017 revenue.

It's perhaps no surprise, then, that the company is steeling for new competition. 

The company's new product, Ultomiris, is intended to be a next-generation version of the drug. Ultomiris extends the timeline that patients have to get dosed, from bi-weekly to every eight weeks; it also conveniently provides new patent protections for the biotech.

Alexion got Ultomiris approved last week, and its plans to switch patients over "will matter a lot," Yee said. 

3. The first cannabis-derived drug in the US

The best known compound in cannabis is THC, but another, non-psychoactive component, CBD, powers the medication Epidiolex, the first cannabis-derived drug in the US. 

The prescription medication, made by GW Pharmaceuticals, was approved over the summer for two rare childhood seizure disorders and just launched November 1.

Read more:A drug derived from marijuana has triggered the first federal shift on cannabis in half a century, and experts predict an avalanche effect

4. Two rare disease drugs in a space that once had no medications at all

When Alnylam's Onpattro was approved in August, it became the first US treatment for the rare, progressive disease ATTR amyloidosis.

Now, there are two drugs for the disease: Onpattro and Ionis/Akcea's Tegsedi, which was approved by the FDA in October. Though distinct, both are intended for the nerve damage and pain that come with ATTR amyloidosis. 

ATTR amyloidosis is known to be difficult to diagnose, and patients didn't have many options until recently, so finding patients will be the next challenge for the biotech companies.

5. A medication that could be the first for postpartum depression

Of the nearly 4 million births that happen each year in the US, nearly 15% of those new mothers are affected by an extended postpartum depression.

Treatment options include antidepressants and counseling, but there could soon be another option: the biotech Sage Therapeutics' Zulresso.

If approved, Zulresso would be the first medication approved specifically for postpartum depression. Zulresso is being reviewed by US drug regulators, and a decision is expected by March 19, 2019. 

Read more:A pharma CEO says a new depression drug could have lasting effects after one short course, like antibiotics — here's what experts think

6. A fish oil-based drug with possible heart health benefits

A common claim about fish-oil supplements is that they're good for your heart, but there isn't evidence to back it up. 

So imagine the surprise when Amarin Pharmaceuticals' Vascepa, which is derived from fish oil, showed promise in reducing cardiovascular risk in a large, multiyear clinical trial. 

Further data will be of interest to investors, but there's "potential for M&A either way," Yee said. 

7. An antidote for life-threatening bleeding

Drugs called anticoagulants are used to treat conditions such as strokes and pulmonary embolisms, a type of artery blockage. One particular type, factor Xa inhibitors, has become increasingly popular, but it has a major complication: bleeding.   

Portola Pharmaceuticals' Andexxa, approved in the US in May, is used to reverse anticoagulation in cases when patients have life-threatening or uncontrolled bleeding. The product has since been taken to market and brought in nearly $8 million in sales in its first full quarter. 

8. A medication for patients with aggressive breast cancer

Triple-negative breast cancer is an aggressive form of the disease, quicker to recur and spread. Immunomedics' IMMU-132 is intended for patients who have already failed to respond to at least two other medications for the disease. A US approval decision is expected by late January, and if the drug is approved, it "will have a lot of focus," according to Yee. 

9. A Parkinson's disease drug launch spurring existential questions for a biotech

Parkinson's disease drugs can do a lot of good for patients, but, as the disease progresses, they don't work optimally all of the time. Acorda Therapeutics' Inbrija got approved by the FDA last week for intermittent treatment of those "off" episodes and is expected to become available by the first quarter of next year. 

The approval decision, which came early, is also bringing new attention to what will become of the company — whether it will work to sell Inbrija, or sell itself instead. Notably, Parkinson's disease drugs are considered "strategically valuable," Stifel analyst Paul Matteis pointed out after the late December approval. 

10. A multiple myeloma drug with an FDA decision expected by April

The biotech Karyopharm Therapeutics could get an FDA approval decision for its multiple-myeloma drug Selinexor by April 6, 2019. 

11. The gene therapy behind a $9 billion acquisition that could threaten another biotech

When Swiss drug-giant Novartis acquired the biotech AveXis for nearly $9 billion, the pharmaceutical company was clear about its intentions.

AveXis' lead product, AVXS-101, could be the "first-ever one-time gene-replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with considerable healthcare costs," Novartis said in April.

The gene therapy, now being called Zolgensma, could also pose a major competitive threat to Biogen's crucial spinal muscular atrophy therapy Spinraza. 

The FDA has agreed to look at Novartis' Zolgensma application, and a decision is expected in May.

12. An ovarian-cancer drug from a Shanghai-based biotech

The Shanghai-based biopharmaceutical company Zai Lab Limited is carrying out its first launch, for the ovarian-cancer drug Zejula in Hong Kong. Zejula is also up before the China National Medical Products Administration, where a much larger patient population could be in reach.

These could prove a "key read-through for Asia biotech," Yee said, which has attracted US investment interest of late but has also been hit by wider market conditions. 

Join the conversation about this story »

NOW WATCH: The reason some men can't grow full beards, according to a dermatologist

• It's important to discuss salary with your coworkers.
• But sometimes you might hear information that you wish you hadn't learned — like, for instance, that a coworker in a similar role is making way more than you are.
• Here's what to do if you find out your coworker makes more than you.

So, you asked your coworkers about their salaries— and found out that, even though they're in a similar role to yours, they're making way more than you are. Now what?

First of all, stay calm.

Next, don't run to your boss and demand a raise, said Katie Donovan, a salary negotiation coach.

"If you do find out that others are earning more, do not rush to your manager demanding more 'because so and so earns more,'" Donovan told Business Insider. 

Anna Cosic, career strategist, agrees. "It's important to note that the information you eventually gather is not intended to be used towards HR or your manager saying that since X is making $Y, so should I," Cosic said. "That rarely pays off and they may have several different reasons that someone makes more than you do."

But, you should ask for a raise — calmly

Plan out a meeting with your boss in which you show why you deserve to make more. As we've previously reported, any good salary negotiation presents a case for your promotion based on data.

That data should show that you have excelled in your role. Vicki Salemi, career expert for Monster, told Business Insider you should already know the quantitative ways that your company measures performance. Think sales goals, output, or another barometer. 

A bonus just for you: Click here to claim 30 days of access to Business Insider PRIME

That data should also show that the number you're asking for is on par with what folks in your position normally make. Check out salary data websites like Payscale, Glassdoor, Indeed, and Salary to see the median pay for your industry, position, and location.

Don't tell your boss you know how much your peers make

When you talk to your boss, don't say that you know your coworkers make more than you do — and definitely avoid name dropping or number dropping. That could cause negative repercussions for your coworker.

When it comes down to it, your company "may have several different reasons that someone makes more than you do," Cosic said. 

Instead, MarketWatch suggests saying something like: "It was brought to my attention that the market value for my position is X." 

That way, you can protect your coworkers while still (hopefully) securing more money for yourself. 

SEE ALSO: Here's how to ask your coworkers how much they're making, according to experts

Join the conversation about this story »

NOW WATCH: Barbara Corcoran doesn't invest in rich kids because poor kids have one trait that makes them more likely to succeed

• Sam Shank, CEO of booking app HotelTonight, gets up at 5:15 every morning, even though he wasn't always a morning person.
• He says that starting his morning with a workout class helped him adjust to the new routine.
• The penalties incurred by missed classes and the expectation of seeing the same people in workout classes were key parts of making the change stick.

Sam Shank wasn't always a morning person. Nowadays, though, the HotelTonight CEO starts every morning bright and early.

"I get up at 5:15 every morning, and if you'd told me five years ago that I'd be getting up that early, I'd be like, 'you're crazy,'" he recently told Business Insider.

As someone who wasn't necessarily hardwired for early mornings, Shank used to exercise after work. However, moving those workouts to the beginning of the day proved "transformational" for his lifestyle: Getting his exercise — which varies from HIIT workouts and boot camp classes to pilates and yoga — done in the morning allows him to be in the office by 7:30 a.m. and fuels him with energy for the whole day. It also frees up time in the evening to spend with his family.

As for the trick that got him to stick to the routine, Shank found the solution in gym classes.

"It was committing to an exercise class," he said. "There's a penalty if you don't show up at Equinox or ClassPass ... and there's an expectation where you see the same people all the time."

"That commitment was key for me," he added.

Shank launched the online travel company in January 2011. Users are able to book discounted, last-minute hotel rooms via its app or mobile site, and they can access a wide range of hotels across international destinations.

Read more: The CEO of a top travel app says the best boutique hotels all have the same 2 things in common, no matter what city they're in

His morning routine puts him in good company. Early mornings are a common feature of many successful peoples' routines, from actors like Melissa McCarthy, who gets up at 4:30 a.m. and starts her day with a "carefully curated" routine to CEOs like Tim Cook, who reportedly starts his day at 3:45 a.m.

But a morning workout is just one way in which the CEO is deliberate with his time.

He also noted that he blocks out what he calls "Sam time" on his calendar: two- to three-hour chunks that he purposely leaves unplanned and unscheduled. He uses that time for anything from talking to members of his 260-person team and checking in with mentors to delving into any given detail of his company's work.

"I made it a goal for my assistant to put those in my calendar for five hours a week," Shank explained.

SEE ALSO: I interviewed over 300 highly successful people about their morning routines — here are 5 things they do to have a focused and productive day, every day

READ MORE: What your daily routine should look like, according to science

Join the conversation about this story »

NOW WATCH: Barbara Corcoran on Donald Trump: 'He is the best salesman I've ever met in my life'

• Costco is selling a tub of Nutella that weighs in at nearly seven pounds. 
• The 6.6-pound Nutella bucket can be purchased in stores or online for $21.99. 
• It is hard to find a better deal on Nutella than this mega-tub of the beloved spread, with customers paying $3.33 per pound.

Costco is selling some super-sized Nutella. 

The bulk retailer has a 6.6-pound tub of Nutella spread for $21.99, a deal spotted by BestProducts.com. 

If you order online— where the bucket of hazelnut spread is available for purchase — you have to pay an extra $3 delivery fee. Costco doesn't require a membership to shop online, but a membership is necessary to access two-day delivery. 

Read more:We compared Costco and Jet prices to see which company offers better deals. Here's the verdict.

It's hard to find a better deal on Nutella than this mega-tub of the beloved goop, with customers paying $3.33 per pound of Nutella. Costco shoppers can also purchase two 33.5-ounce jars of Nutella for $13.99. 

Costco is known for its low prices and sometimes surprising deals. Now, alongside wine, coffins, and engagement rings, you can pick up a massive Nutella bucket. 

SEE ALSO: 7 things you probably didn't know you can buy at Costco

Join the conversation about this story »

NOW WATCH: The true story behind the name 'Black Friday' is much darker than you may have thought

• Awesome Games Done Quick, a charity video game marathon, begins on January 6th and will run until midnight on January 13th.
• The event runs nonstop all week — all told, it'll run for 168 consecutive hours of gameplay, with players and games swapping out over the course of the marathon.  
• Players will be speedrunning dozens of different games, and can earn extra money for charity by beating them as quickly as possible.
• Games Done Quick, the organization behind AGDQ, has helped raise nearly $17 million for charity since it started the event in 2011.

Awesome Games Done Quick, a charity speedrunning marathon, begins today, January 6th, and will run for 168 consecutive hours until midnight on January 13th. The week-long event will benefit Doctors without Borders and the Prevent Cancer Foundation, and is the largest single global fundraising event for both organizations.

Hundreds of players and video game fans will fill the Marriot Bethesda North Hotel in Rockville, Maryland for AGDQ this week, and hundreds of thousands more will tune in to watch on Amazon's Twitch.

Games Done Quick, the organization behind the marathon, has raised more than $17 million for charity since 2011. Along with AGDQ, the organization hosts Summer Games Done Quick, and has put together smaller fundraisers for specific causes, like 2017's Harvey Relief Done Quick.

The speedrunning community is a group of hardcore video game players dedicated to beating specific games as quickly as possible. Dedicated players spend hours studying the fastest routes and techniques to shave fractions of seconds off their times, and share video and strategy of their runs online. Speed Demos Archive, a sister site to Games Done Quick, archives videos of record speed runs, and serves as an organizing base for the community.

The selection of games this year spans every console generation, from the original "Sonic the Hedgehog" to more recent hits like "Super Mario Odyssey" and "Dead Cells."

Viewers at home can tune in and donate throughout the week-long event, and messages attached to their donations are read live on the broadcast. AGDQ 2018 peaked at 198,744 concurrent viewers and brought in a record $2.295 million from 32,368 different donors. The largest individual donation was $108.092.32.

As one of the community's premiere events, Awesome Games Done Quick has been home to multiple world record runs, too. Some players offer additional donation incentives, like completing their game on a harder difficulty if a viewer donates more than $100 during their session.

Below you can watch AGDQ starting at 11:30 a.m. PT on January, 6th; be sure to check the schedule to find specific times for each game, including how long the run will take.

Awesome Games Done Quick mobilizes a unique community that is also crazy entertaining to help raise millions for great causes. No matter how the gaming actually goes, everybody winds up a winner. 

SEE ALSO: Watch this gamer beat 'Super Mario Bros.' in under five minutes and set a new world record in the process

Join the conversation about this story »

NOW WATCH: Why NASA blasts half a million gallons of water during rocket launches

The Insider Picks team writes about stuff we think you'll like. Business Insider may receive a commission from The Points Guy Affiliate Network.

• When American Express launched its new American Express® Gold Card in October, it also introduced a special, limited-edition rose gold version of the card. 
• The new design — the regular version of the new Gold Card is a metallic gold — comes in addition to competitive rewards on restaurants and supermarkets in the US, airfare, and more.
• You can request the rose gold card if you're a new applicant, or currently hold AmEx's previous version of the card, the Premier Rewards Gold. 
• However, the rose gold version is only available until January 9.
• New cardholders can also get a unique, limited-time welcome bonus if they apply before the same date.
• Here's what you need to know about the AmEx Gold Card.

SEE ALSO: The AmEx Platinum is available to active duty servicemembers at no annual fee — but even with the fee, the credit card is a great value

Join the conversation about this story »

• Acting White House chief of staff Mick Mulvaney says negotiations to end the government shutdown are "back at square one."
• Mulvaney says Democrats will not negotiate around the White House's demand for $5.6 billion for border security. 
• The statements come a day after Saturday's shutdown negotiations, which President Donald Trump and Mulvaney said were unproductive. 

Acting White House chief of staff Mick Mulvaney took to Sunday morning TV to deliver the White House's grim message on the partial government shutdown: "We're back at square one."

"We're at $5.6 billion. And I think they're at zero," Mulvaney told Chuck Todd on "Meet the Press," referencing the $5.6 billion that the White House is demanding be added to the spending bill that currently has Congress in a deadlock and the federal government at a partial standstill. 

"It’s status quo," he continued, "it's the same money you had from last year. The status quo is not acceptable right now and that's all the Democrats are offering us.”

The statements come a day after Vice President Mike Pence and other top Trump administration staff met with Democratic Congressional leaders in an attempt to find a middle ground on a spending bill. Following the meeting, Pence's office called the discussions "productive," but Trump tweeted "Not much headway made today," and Mulvaney told CNN "the opening line from one of the lead Democrat negotiators was that they were not there to talk about any agreement."

Read more:Trump and Pence offered completely different accounts of a meeting to resolve the government shutdown

Another meeting is scheduled for Sunday, but Trump himself said he didn't expect much progress to be made.

The White House and Democratic leaders are currently locked in a battle over funding for border security. The Trump administration is demanding a $5.6 billion allocation for its proposed "wall," while Democrats are attempting to negotiate that number down.

On CNN's State of the Union, Democratic Senator Doug Jones of Alabama echoed the party line, saying, "I do not believe that holding government workers and all those affected by government services hostage is the way to determine how best to secure our borders, which everyone wants."

An estimated 800,000 Americans are currently furloughed or working without pay until the shutdown ends.

SEE ALSO: SHUTDOWN SHOWDOWN: Trump threatens to close the government for 'months or even years' to get border-wall funding

Join the conversation about this story »

NOW WATCH: Why Harvard scientists think this interstellar object might be an alien spacecraft

• Senior Labour source denies claim that Labour plans to abstain on the upcoming vote on May's Brexit deal.
• A website known to be close to Corbyn's senior team claimed the party could abstain in order to force the DUP to abandon May's government and force a general election.
• Any abstention by Labour MPs could allow May to pass her deal with the EU. 
• However a source close to Corbyn told Business Insider that the claims have "no basis in fact."

LONDON — A senior Labour source close to the Labour leader Jeremy Corbyn has dismissed suggestions that the party will abstain on the upcoming meaningful vote on the Brexit deal as having "no basis in fact."

A post published on Sunday by the website Skwawkbox, which is known to be close to figures in Corbyn's senior team, suggested that the party could abstain on the vote in order to secure support from the Democratic Unionist Party for triggering an early general election.

However, a source close to Corbyn told Business Insider that the claim about Labour's Brexit tactics "has no basis in fact."

"This piece doesn't represent our position at all," the source said.

"The story has no basis in fact. It is not a scenario anyone is thinking about."

The DUP, which props up May's minority government, has promised to vote against May's deal when it comes before Parliament later this month but withdraw its support from the government entirely if the vote on the deal passes.

This has led to the suggestion that Labour could abstain in order to force a fatal blow to May's governing majority.

"The key to Labour’s tactics over the coming two weeks or so will be the DUP," the website wrote on Sunday.

"Labour could not support May’s deal – but an abstention on [the meaningful vote] would bring things to the point where the DUP would be faced with a choice between bringing down the government or living with a backstop that would put it on a probably permanently-different basis to the rest of the UK...

"This could see a no-confidence vote in play, probably on Jan 22 – opening the door to a general election by 21 March and the opportunity for a Corbyn government to seek an extension to Article 50 when the EU commission meets that week."

The claim comes as the party comes under growing pressure to back a second Brexit referendum.

The Shadow International Trade Secretary Barry Gardiner told the BBC's Andrew Marr Show that backing a so-called People's Vote now would "divide" the country.

"It is the responsibility of government to unite the country not divide it," he said, adding that an incoming Labour government would instead seek to negotiate "a different, better deal," with the EU.

The Shadow Foreign Secretary also accused the People's Vote campaign of using the issue to attack the Labour party.

"I think some people within the People’s Vote movement seem to think that their purpose is to slap the Labour party around," she told BBC 5Live’s Pienaar’s Politics.

Sources close to the Labour leader have previously told Business Insider that they are extremely reluctant to back another referendum.

They claim the party has conducted private polling and focus groups in key marginal seats the party is targeting, which suggest that doing so could cost Labour the next general election.

Join the conversation about this story »

NOW WATCH: Anthony Scaramucci claims Trump isn't a nationalist: 'He likes saying that because it irks these intellectual elitists'

• Senior Labour source denies claim that Labour plans to abstain on the upcoming vote on May's Brexit deal.
• A website known to be close to Corbyn's senior team claimed the party could abstain in order to force the DUP to abandon May's government and force a general election.

• Any abstention by Labour MPs could allow May to pass her deal with the EU. 
• However a source close to Corbyn told Business Insider that the claims have "no basis in fact."

LONDON — A senior Labour source close to the Labour leader Jeremy Corbyn has dismissed suggestions that the party will abstain on the upcoming meaningful vote on the Brexit deal as having "no basis in fact."

A post published on Sunday by the website Skwawkbox, which is known to be close to figures in Corbyn's senior team, suggested that the party could abstain on the vote in order to secure support from the Democratic Unionist Party for triggering an early general election.

However, a source close to Corbyn told Business Insider that the claim about Labour's Brexit tactics "has no basis in fact."

"This piece doesn't represent our position at all," the source said.

"The story has no basis in fact. It is not a scenario anyone is thinking about."

The DUP, which props up May's minority government, has promised to vote against May's deal when it comes before Parliament later this month but withdraw its support from the government entirely if the vote on the deal passes.

This has led to the suggestion that Labour could abstain in order to force a fatal blow to May's governing majority.

"The key to Labour’s tactics over the coming two weeks or so will be the DUP," the website wrote on Sunday.

"Labour could not support May’s deal – but an abstention on [the meaningful vote] would bring things to the point where the DUP would be faced with a choice between bringing down the government or living with a backstop that would put it on a probably permanently-different basis to the rest of the UK...

"This could see a no-confidence vote in play, probably on Jan 22 – opening the door to a general election by 21 March and the opportunity for a Corbyn government to seek an extension to Article 50 when the EU commission meets that week."

The claim comes as the party comes under growing pressure to back a second Brexit referendum.

The Shadow International Trade Secretary Barry Gardiner told the BBC's Andrew Marr Show that backing a so-called People's Vote now would "divide" the country.

"It is the responsibility of government to unite the country not divide it," he said, adding that an incoming Labour government would instead seek to negotiate "a different, better deal," with the EU.

The Shadow Foreign Secretary also accused the People's Vote campaign of using the issue to attack the Labour party.

"I think some people within the People’s Vote movement seem to think that their purpose is to slap the Labour party around," she told BBC 5Live’s Pienaar’s Politics.

Sources close to the Labour leader have previously told Business Insider that they are extremely reluctant to back another referendum.

They claim the party has conducted private polling and focus groups in key marginal seats the party is targeting, which suggest that doing so could cost Labour the next general election.

Join the conversation about this story »

NOW WATCH: Anthony Scaramucci claims Trump isn't a nationalist: 'He likes saying that because it irks these intellectual elitists'

This is a preview of a research report from Business Insider Intelligence, Business Insider's premium research service. To learn more about Business Insider Intelligence, click here.

The US prepaid card ecosystem is huge, with 10.7 billion prepaid card transactions made in 2016 reaching $290 billion. And it’s shifting focus from low-income, un- and underbanked consumers toward millennials and higher-income adults.

But as the market evolves, legacy prepaid issuers, like Green Dot, are under threat. The market is becoming more competitive as tech companies like Apple, Square, and Venmo develop their own prepaid offerings, likely as part of a push to drive customers to engage with their core peer-to-peer (P2P) transfer or digital wallet apps. These players’ robust digital offerings and ability to offer prepaid services for lower, or no fees are undercutting legacy businesses. And on top of crowding, the Consumer Financial Protection Bureau (CFPB) is implementing regulations next year that could impact some issuers’ monetization strategies.

As a result, the US prepaid card market is becoming an increasingly complicated space for issuers to navigate, so prepaid issuers need to rethink their strategies to best attract consumers. Companies can attract a bigger user base if they target younger users from both low-income and high-income segments. They should also provide convenient offerings, that integrate digital features to make account information accessible, to cater to young consumers’ preferences.

Business Insider Intelligence has put together a detailed report that explores the evolving prepaid card industry, identifies how issuers can maintain profitability in a market that’s being challenged by new players and impending government regulations, and evaluates various paths to success.

Here are some key takeaways from the report:

• There were 10.7 billion prepaid card transactions worth $290 billion in 2016, according to The Federal Reserve. Business Insider Intelligence expects that to grow to $396 billion by 2022. 
• The prepaid space has historically been filled with incumbents like Green Dot. But new players, like Apple, Amazon, and Venmo, are trying to gain share, which is pushing large prepaid firms to merge or acquire one another to grow.
• Issuers can adapt to the change in the space, and grow their share of the market, by providing convenient, multichannel access, and doing so in a way that facilitates profitability. Targeting younger consumers, both from the underbanked and high-income segments, as well as accessing users from physical as well as digital channels, can help facilitate this growth.

In full, the report:

• Sizes the US prepaid card market and estimates its future trajectory.
• Identifies industry leaders and the newcomers to prepaid that are threatening their market share.
• Evaluates growth factors and inhibitors that are increasing competition in the space.
• Issues recommendations and strategies that issuers can implement to stay ahead in such a rapidly shifting space.

Subscribe to an All-Access pass to Business Insider Intelligence and gain immediate access to:

	This report and more than 250 other expertly researched reports
	Access to all future reports and daily newsletters
	Forecasts of new and emerging technologies in your industry
	And more!

Learn More

Purchase & download the full report from our research store

Join the conversation about this story »

• Mark Benioff, Salesforce’s founder, chairman and co-CEO, said he’s targeting $20 billion in sales by 2022 in an interview with CNBC.
• Salesforce had $10.48 billion in sales in 2018, nearly a 25% increase from 2017.
• In March, Salesforce acquired MuleSoft, a tech company that allows developers to connect different apps together, in a deal valued at $6.5 billion.

The calendar might have just flipped to 2019, but Salesforce’s Mark Benioff already has expectations for 2022.

The founder, chairman and co-CEO of the San Francisco-based software company said he’s targeting $20 billion in sales for 2022 in an interview with CNBC.

Salesforce had $10.48 billion in sales in 2018, a 24.88% uptick from 2017.

Read more:The rise of Marc Benioff, the bombastic Salesforce CEO who's buying up Time Magazine for $190 million

Benioff’s goal for 2022 is roughly on par with the growth of the company’s sales in recent years. Since 2014, Salesforce has increased sales by over 106%.

However, the company had a volatile end to 2018. After Salesforce stock reached a company-high of $160 per share in September, its value dropped nearly 24% in the ensuing months. Still, Salesforce shares jumped 5% after the company offered a ‘beat and raise’ in its third-quarter earnings report at the end of November. Salesforce shares are currently valued at $137.96.

A key part of Salesforce’s continued growth will be MuleSoft, which it acquired last year for a deal valued at $6.5 billion. MuleSoft offers cloud services, like Salesforce, to allow developers to connect different apps together.

SEE ALSO: Salesforce has lost nearly 24% of its value since September — here's why Wall Street has high hopes for its Tuesday earnings report

Join the conversation about this story »

NOW WATCH: The equity chief at $6.3 trillion BlackRock weighs in on the trade war, a possible recession, and offers her best investing advice for a tricky 2019 landscape

• New York Gov. Andrew Cuomo announced on Thursday that New York City's L train would not shut down for 15 months as previously planned.
• While some residents are rejoicing that their commute will no longer be impacted, experts say the change in plan could drive up rental prices substantially.
• Residents who have already secured cheaper rent as a result of the planned closures could also see prices rise, according to a real estate lawyer. 

Since New York City's Metropolitan Transit Authority announced it would be closing its L train — a major transit link between areas of Brooklyn and Manhattan — rental prices in the impacted neighborhoods have dropped substantially as landlords lowered rent to entice new residents and convince others to stay. 

These lower rents came into question on Thursday after New York Gov. Andrew Cuomo halted plans to close the subway route and announced that the city would be using new technology, used in Europe for tunnel construction, to avoid having to fully close the line. 

Officials had said in 2016 that the L train would need to be shut down starting in April so that the MTA could repair flood damage left over from Hurricane Sandy. 250,000 people commute via the L train daily. 

Read more: New York Governor Andrew Cuomo axes plan to shut down the L Train, saves Brooklynites from commuting hell

Experts are expecting rental prices to shoot back up as a result, and some say that those residents who have already secured cheaper rents could also be impacted.

Michael Lefkowitz, a real estate lawyer at New York-based firm Rosenberg & Estis, told Business Insider that it is likely that some landlords would have included concession clauses in their leases. These clauses might say, for example, that the lower rents being offered are dependent on the L train closing down. Now that the train line is no longer slated to close, tenants may not be eligible for those deals anymore. 

"It all depends on how any of these concession clauses have been drafted," he said. "If there is no contingency on whether the L train closed, then the rent is lower."

Those who don't have such clauses in their leases have gotten lucky, experts say. 

"Renters who have managed to negotiate deals in recent months have struck gold,"StreetEasy's senior economist, Grant Long, said in a comment emailed to Business Insider on Thursday.

Long said that rents in North Brooklyn have fallen a cumulative 1.5% since the shutdown was first announced in April 2016, while rents in the rest of the borough have increased by a cumulative 3.3%.

"I think some people got a very nice, happy new year gift," Dave Maundrell, executive vice president of new developments for Brooklyn and Queens at brokerage firm CitiHabitats, told Business Insider on Thursday. 

Micahel Allen, executive manager of sales at Douglas Elliman, echoed this.

"Tenants who signed leases in the last year or so are patting themselves on the back right now," he said in an email to Business Insider on Friday. 

Once a lease has been executed by both parties, providing there are no clauses, the terms are binding.

"The landlord would not be able to renegotiate the terms during the lease period,"Jessica Peters, a real estate broker for Douglas Elliman in Williamsburg, told Business Insider. 

The only way a landlord could wriggle out of these terms is when the lease expires, she said. At this point, residents could see prices shooting back up.

"Concessions are probably going to get reduced quickly," Maundrell said. "And when leases expire, previous concessions are going to burn off, without question." 

• Read more on the cancellation of the L train shutdown:
• New York Governor Andrew Cuomo axes plan to shut down the L Train, saves Brooklynites from commuting hell
• New York's governor just killed a plan to shut down one of the most crowded subway lines in NYC — and people are freaking out
• New York's governor called Tesla to see if the company could help fix NYC's subway system
• New York Governor Andrew Cuomo killed a controversial plan that would have caused commuting hell for thousands of people — but it's terrible news for people moving to the area
• People are slamming New York's governor for taking over 2 years to come up with a plan to avoid shutting down one of NYC's busiest subway lines

Join the conversation about this story »

NOW WATCH: Almost 80% of the textbook industry is dominated by 5 publishing companies that make books so expensive most students skip buying them

• President Donald Trump said Sunday that he "can relate" to the hundreds of thousands of federal workers who were furloughed or forced to work without pay during the government shutdown.
• Trump said the employees will "make adjustments" during the shutdown that has caused them to go without pay, because "many...agree with what I'm doing."
• As lawmakers tangle with the Trump administration over funding for a border wall, nearly 800,000 federal workers were affected by the shutdown and facing unsure weeks ahead as they wait for their paychecks to come.

President Donald Trump said Sunday that he "can relate" the hundreds of thousands of federal workers who have been without paychecks since the government entered a partial shutdown over two weeks ago.

"I can relate and I'm sure the people who are on the receiving end will make adjustments, they always do," Trump said to reporters as he left the White House for Camp David.

Trump continued: "But many of those people who won't be receiving a paycheck, many of those people agree with what I'm doing."

Around 800,000 federal employees were affected by the shuttered agencies, 380,000 of which are now on furlough, meaning they do not report to work or get paid.

Read more: 'We don't know when his next check will come': Federal employees are sharing how the government shutdown over Christmas is affecting their families

An INSIDER poll conducted last week found most Americans would prefer the $5 billion Trump is demanding for border security be allocated toward other policy goals, including healthcare expenses, infrastructure, and early-childhood education programs.

The shutdown, which is the fourth-longest in history, has no clear end in sight, with Acting White House chief of staff Mick Mulvaney saying Sunday that recent negotiations with Democratic lawmakers were "back at square one."

SEE ALSO: Acting chief of staff Mulvaney says shut down negotiations have stalled: 'We're back at square one'

DON'T MISS: Trump and Pence offered completely different accounts of a meeting to resolve the government shutdown

Join the conversation about this story »

NOW WATCH: Anthony Scaramucci claims Trump isn't a nationalist: 'He likes saying that because it irks these intellectual elitists'

• Every week, Parrot Analytics provides Business Insider the most in-demand TV shows on streaming services.
• This week includes DC Universe's "Titans" and Netflix's "Stranger Things."

Netflix announced on New Year's Day that "Stranger Things" will return on July 4, pushing up audience interest. 

Every week, Parrot Analytics provides Business Insider with a list of the seven most "in-demand" TV shows on streaming services. The data is based on "demand expressions," the globally standardized TV demand measurement unit from Parrot Analytics. Audience demand reflects the desire, engagement, and viewership weighted by importance, so a stream or download is a higher expression of demand than a "like" or comment on social media.

Below are this week's seven most popular shows on Netflix and other streaming services:

SEE ALSO: Disney won't make big-budget movies like 'Star Wars' for its Netflix competitor

7. "Voltron: Legendary Defender" (Netflix)

Average demand expressions:  21,834,399 

Description: "In an all-new series, five unlikely heroes and their flying robot lions unite to form the megapowerfulVoltron and defend the universe from evil."

Rotten Tomatoes critic score (Season 8): N/A

What critics said: "This feels like a series that could have lasted several more seasons, at least. But if it has to end now, at least it's going out in top form."  — Jesse Schedeen, IGN

Season 8 premiered on Netflix December 14.

6. "Chilling Adventures of Sabrina" (Netflix)

Average demand expressions:  25,102,990 

Description: "Magic and mischief collide as half-human, half-witch Sabrina navigates between two worlds: mortal teen life and her family's legacy, the Church of Night."

Rotten Tomatoes critic score (Season 1): 90%

What critics said: "Chilling Adventures of Sabrina is great television for the seriousness with which it engages in the subtext of its horror trappings. Curses, demons, spirits, and hauntings-they're supernatural analogues that largely stem from old injustices."— Joshua Rivera, GQ

Season 1 premiered on Netflix October 26.

5. "Marvel's Daredevil" (Netflix)

Average demand expressions: 25,209,685 

Description: "Blinded as a young boy, Matt Murdock fights injustice by day as a lawyer and by night as the Super Hero Daredevil in Hell's Kitchen, New York City."

Rotten Tomatoes critic score (Season 3): 96%

What critics said: "Every Netflix MCU show has sought to imitate the first season of Daredevil in some way, with decidedly mixed results. Season 3 shows that Daredevil still does Daredevil best."— Samantha Nelson, The Verge

Season 3 premiered on Netflix October 19. The show was recently canceled.

• President Donald Trump announced Sunday that the US military has killed notorious al-Qaeda operative Jamel Ahmed Mohammed Ali Al-Badawi, confirming earlier reports.
• Al-Badawi, who has been on the FBI's list of most wanted terrorists, is said to have orchestrated the bombing off the USS Cole in 2000 that killed 17 American sailors.
• "Our GREAT MILITARY has delivered justice for the heroes lost and wounded in the cowardly attack on the USS Cole," the president tweeted Sunday.

The US military has killed the terrorist mastermind believed to have orchestrated the deadly USS Cole bombing eighteen years ago, the president revealed Sunday, confirming earlier reports.

Jamel Ahmed Mohammed Ali Al-Badawi, an al-Qaeda operative on the FBI's most wanted list, was killed during a strike in Yemen's Ma'rib Governorate, a US official told CNN. He was struck while driving alone. The US says there was no collateral damage.

That Al-Badawi was the target of Tuesday's airstrike was confirmed by Voice of America, citing a defense official. As of Friday afternoon, US forces were reportedly still assessing the results of the strike.

President Donald Trump confirmed Sunday that the US military successfully eliminated Al-Badawi.

The bombing of the USS Cole, an Arleigh Burke-class guided-missile destroyer, occurred while the warship was refueling at Yemen's Aden harbor. On October 12, 2000, suicide bombers in a small boat filled with explosives attacked the ship, killing 17 US sailors and wounding another 39 people.

Al-Badawi had been picked up by Yemeni authorities multiple times since the bombing; however, he repeatedly managed to escape justice.

After being arrested in December 2000, he escaped in 2003. He was apprehended a second time in 2004, but he managed to escape again two years later.

He was indicted by a federal grand jury in 2003 and charged with 50 counts of terrorism-related offenses. The FBI has been offering a reward of up to $5 million for information that would lead to his arrest.

Join the conversation about this story »

NOW WATCH: The reason some men can't grow full beards, according to a dermatologist

The Insider Picks team writes about stuff we think you'll like. Business Insider has affiliate partnerships, so we get a share of the revenue from your purchase.

• Dandy Blend, an herbal coffee substitute, features dandelion root, chicory root, barley, and rye and tastes just like the real thing.

• Coffee, with its high acid content and diuretic properties, can lead to dry, inflamed skin, but Dandy Blend is packed with vitamins and nutrients that aid in the overall health of the body — including skin health.

Quitting coffee is one of those things I dabble in, without fail, at the beginning of every new year.

Intellectually, I know the habit isn't great for my body — but I always go back to it because, as researchers have shown, caffeine addiction is real. Some of the symptoms of coffee withdrawal prove it: Headaches, fatigue, and irritability set in when the caffeine-spiked morning Venti goes away.

I have another theory about coffee addiction, though. In my experience, the habit of making, pouring, grabbing, and sipping on a cuppa is just as addictive as the caffeine itself. When my hand is grasped around a warm mug and that sweet-bitter taste hits my tongue, I feel like the day has officially begun. So when I made up my mind to quit coffee once and for all, I knew I needed a replacement habit — something that would easily fit into my already-established morning routine and trick my body into perking up.

Enter herbal coffee, or more specifically, Dandy Blend.

Dandy is an herbal blend featuring dandelion root, chicory root, barley, and rye. It looks strikingly similar to instant coffee and is just as easy make; you simply scoop a heaping tablespoon or two into a hot cup of water and stir. Voilá!"Java" is served. But where Dandy differs from other herbal coffee alternatives I've tried is that it actually tastes like the real thing. Chicory root mimics that full-bodied coffee taste I've grown to love, but in a slightly earthier way.

With Dandy Blend in my cup, my first two coffee-free weeks flew by without any of the headaches and irritability I anticipated… probably because Dandy Blend is more than just a coffee substitute — it's actually healthy. Whereas coffee is highly acidic (which can cause heartburn and stomach issues) and a diuretic (which leaves the body dehydrated), Dandy Blend can reduce inflammation in the body (thanks to dandelion root) and regulate digestion (courtesy of barley and chicory root).

But the biggest change I noticed from cutting out coffee? My skin started to G-L-O-W.

"Coffee may cause insulin resistance, which is your body's ability to process sugar, and that can stimulate your sebaceous glands to produce extra oil," Jill Therese, a skin and nutrition specialist and the founder of Heal Your Face With Food, tells Business Insider. "Excess oil can lead to blocked pores on the skin and potential breakouts." Additionally, the caffeine content in coffee directly stimulates the adrenal glands. "This overstimulation of the adrenals over time can lead to dehydration and premature aging down the road," Therese says. So if you struggle with problem skin and consume coffee on a daily basis, you may want to cut back to see if caffeine is the culprit.

My improved skin tone wasn't just a result of eliminating coffee — it turns out, Dandy Blend is full of glow-inducing vitamins and minerals, too. "Dandelion root is like the nectar of the gods for your skin because of its ability to support the liver's detoxification process," Therese notes.

The liver has long been connected to skin issues, since it's basically the body's detox center. When the liver isn't functioning properly, it doesn't filter toxins out of the body, and these toxins can show up on your skin in the form of pimples, rashes, and even eczema and psoriasis. "Dandelion increases the flow of bile in the liver and as a result, all excess hormones and toxins are efficiently processed out of the body," Therese explains. "This leads to better digestion, less stress, and much clearer skin."

The chicory root in Dandy Blend helps as well. It's packed with antioxidants to neutralize the effects of pollution on the skin (like wrinkles, fine lines, inflammation, and age spots) and features high levels of Vitamins A and K — two of the most important vitamins for skin health. Vitamin A is famous for its anti-aging and anti-acne properties, while Vitamin K boosts the body's ability to heal, so skin issues clear up faster and don't leave scars behind.

As soon as I realized that ditching my daily cup of joe in favor of Dandy Blend would lead to better skin, I knew I'd be off coffee for good. I've even altered my go-to Dandy recipe to include additional skin-boosting benefits.

Want my clear skin recipe?

In an eight ounce cup of hot water, I mix together one tablespoon of Dandy Blend, a half tablespoon of bone broth collagen (for plumper, firmer-looking skin), and one tablespoon of coconut oil (since healthy fats help to keep skin moisturized from the inside out). You can also make this with cold water and add ice cubes, if you're into a cold brew-esque experience.

After a week of Dandy, I promise you won't miss coffee — or the inflammation, dehydration, and dull skin that come with it — at all.

Buy Dandy Blend Herbal Coffee at Amazon from $13

SEE ALSO: This $12 magnesium and vitamin C serum brightened my dull, tired skin practically overnight

DON'T MISS: This $8 reusable K-cup filter saves me more than $1,000 a year on coffee

Join the conversation about this story »

• Some fantastic business books are coming out in early 2019.
• For example, you can learn about the financial crisis or learn how to become a top-notch manager.
• Below, we've listed the books we're most eagerly anticipating.

If your New Year's resolution was to read more, we're here to help you out.

The first few months of 2019 have in store some fantastic business books, from an investigation of how incompetent men become leaders, to a guide to making your career dreams a reality, to a biography of Apple CEO Tim Cook. Each one will make you think differently about work, leadership, and success.

Get out your reading glasses — and get excited.

SEE ALSO: The best business books of 2018

'The Surprising Science of Meetings' by Steven G. Rogelberg (Jan. 2)

You know what might be more useful than sitting through an hour-long department meeting? Taking that hour to read a book about why most workplaces are doing meetings all wrong.

Rogelberg is a professor of management at the University of North Carolina at Charlotte, as well as a consultant to organizations including IBM and Procter & Gamble. Based on extensive research and reporting, he put together this guide to more effective meetings.

That doesn't mean eliminating meetings entirely, as some disgruntled employees would have it — instead it might mean holding walking meetings, limiting meeting times to 48 minutes, or instituting periods of silent reading. The book even features an assessment that will diagnose your "meeting quality"— i.e. how much of your day you're currently wasting in conference rooms with your coworkers.

Find it here »

'Be Fearless' by Jean Case (Jan. 8)

Case's book is a welcome kick-in-the-pants for anyone who feels stuck in their career. The first female chairman of the National Geographic Society, as well as a former executive at AOL, Case has broken down success into five guiding principles: make a big bet, take bold risks, capitalize on failure, look beyond your comfort zone, and prioritize urgency over fear.

The book is packed with examples of legendary innovators, from Henry Ford, to Jeff Bezos, to Jose Andres, to Case herself, and the paths that led them to greatness. Some key lessons based on the stories are testing and validating ideas quickly and taking the long view of your life.

Melinda Gates was one of the early readers impressed by the book, saying, "If you need a dose of courage, I recommend this powerful collection of stories, evidence, and optimism."

Find it here »

'The Age of Surveillance Capitalism' by Shoshana Zuboff (Jan. 15)

The monoliths of today's business world are the big tech companies, and unlike corporate giants of the past, they know a scary amount about each of us and hold tremendous sway over our lives. And much of the power they hold takes place in spaces that are unregulated by the government.

In "The Age of Surveillance Capitalism," Harvard Business School professor Shoshana Zuboff explores the deal that makes it all possible, the agreement to sacrifice privacy for benefits like interacting with friends and shopping online.

Zuboff takes an in-depth at how this system has transformed the economy, politics, and society in general, and where we go from here.

Find it here »